𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

✍ Scribed by Kojic, E. M.; Kang, M.; Cespedes, M. S.; Umbleja, T.; Godfrey, C.; Allen, R. T.; Firnhaber, C.; Grinsztejn, B.; Palefsky, J. M.; Webster-Cyriaque, J. Y.; Saah, A.; Aberg, J. A.; Cu-Uvin, S.

Book ID
125485415
Publisher
University of Chicago Press
Year
2014
Tongue
English
Weight
426 KB
Volume
59
Category
Article
ISSN
1058-4838

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety, immunogenicity, and efficacy of
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naΓ―